Dr Catherine Harper-wynne
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
University of Kent
Norway
Biography
Dr Catherine Harper-Wynne is a Consultant Medical Oncologist treating breast cancer at the large district generals of Maidstone and Darent Valley Hospitals. Her research interests have centred around ER+ve breast cancer and as an active clinical trialist was the UK CI for the PALOMA 2 trial involving CDK 4/6 inhibitor. She is an Honorary Senior Lecturer at the University of Kent involved in translational projects including microbubble evaluation of the axilla and triple negative breast cancer. Dr Catherine Harper-Wynne is a Consultant Medical Oncologist treating breast cancer at the large district generals of Maidstone and Darent Valley Hospitals. Her research interests have centred around ER+ve breast cancer and as an active clinical trialist was the UK CI for the PALOMA 2 trial involving CDK 4/6 inhibitor. She is an Honorary Senior Lecturer at the University of Kent involved in translational projects including microbubble evaluation of the axilla and triple negative breast cancer.
Research Interest
She is a member of the National Cancer Research Institute Advanced Breast Cancer Group, NHSE Breast Cancer Expert Group and Secretary of the UK Breast Cancer Group.
